on March 1, 2007
Published online before print March 1, 2007, doi: 10.1161/ATVBAHA.106.126714
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 22, 2006
Accepted on February 19, 2007
Physiological Roles of Vascular Nucleoside Transporters
Michaela Löffler ;
From the Department of Anesthesiology and Intensive Care Medicine (M.L., J.C.M.-G., S.A.E., H.K.E.), Tübingen University Hospital, Tübingen, Germany; Department of Biology (I.R.C.), York University, Toronto, Canada.
* To whom correspondence should be addressed. E-mail: heltzschig{at}partners.org.
Abstract--Nucleoside transporters (NTs) comprise 2 widely expressed families, the equilibrative nucleoside transporters (diffusion-limited channels) and concentrative nucleoside transporters (sodium-dependent transporters). Because of their anatomic position at the blood-tissue interface, vascular NTs are in an ideal position to influence vascular nucleoside levels, particularly adenosine, which among others plays an important role in tissue protection during acute injury. For example, endothelial NTs contribute to preserving the vascular integrity during conditions of limited oxygen availability (hypoxia). Indeed, hypoxia-inducible factor-1-dependent repression of NTs results in enhanced extracellular adenosine signaling and thus attenuates hypoxia-associated increases in vascular leakage. In addition, vascular NTs also contribute to cardiac ischemic preconditioning, coronary vasodilation, and inhibition of platelet aggregation. Moreover, vascular nucleoside uptake via NTs is important for nucleoside recovery, particularly in cells lacking de novo nucleotide synthesis pathways (erythrocytes, leukocytes). Taken together, vascular NTs are critical in modulating adenosine-mediated responses during conditions such as inflammation or hypoxia.
Key words: adenosine signaling • concentrative nucleoside transporter • endothelial barrier • equilibrative nucleoside transporter • hypoxia • inflammation • ischemia • preconditioning
This article has been cited by other articles:
 |
|
 |
|
  H. K. Eltzschig, D. Kohler, T. Eckle, T. Kong, S. C. Robson, and S. P. Colgan Central role of Sp1-regulated CD39 in hypoxia/ischemia protection Blood, January 1, 2009; 113(1): 224 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Heinonen, S. V. Nesterov, K. Liukko, J. Kemppainen, K. Nagren, M. Luotolahti, P. Virsu, V. Oikonen, P. Nuutila, U. M. Kujala, et al. Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men J. Physiol., November 1, 2008; 586(21): 5193 - 5202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Giordano, M. Sebastiani, R. De Giorgio, C. Travaglini, A. Tancredi, M. L. Valentino, M. Bellan, A. Cossarizza, M. Hirano, G. d'Amati, et al. Gastrointestinal Dysmotility in Mitochondrial Neurogastrointestinal Encephalomyopathy Is Caused by Mitochondrial DNA Depletion Am. J. Pathol., October 1, 2008; 173(4): 1120 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Hart, D. Kohler, T. Eckle, D. Kloor, G. L. Stahl, and H. K. Eltzschig Direct Treatment of Mouse or Human Blood With Soluble 5'-Nucleotidase Inhibits Platelet Aggregation Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1477 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Morote-Garcia, P. Rosenberger, J. Kuhlicke, and H. K. Eltzschig HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak Blood, June 15, 2008; 111(12): 5571 - 5580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Eckle, M. Faigle, A. Grenz, S. Laucher, L. F. Thompson, and H. K. Eltzschig A2B adenosine receptor dampens hypoxia-induced vascular leak Blood, February 15, 2008; 111(4): 2024 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Rose and I. R. Coe Physiology of Nucleoside Transporters: Back to the Future. . . . Physiology, February 1, 2008; 23(1): 41 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. J. Bone and J. R. Hammond Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3325 - H3332. [Abstract] [Full Text] [PDF]
|
|